000			02650na a2200349 4500
999			_c895 _d895
003			PC895
005			20200309111147.0
008			130622s2014 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aBrandariz Castelo, José Antonio _92626 _eOtorrinolaringología
100			_aHitt Sabag, Ricardo _91474 _eOncología Médica
245	0	0	_aA randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. _h[artículo]
260			_bAnnals of oncology: official journal of the European Society for Medical Oncology / ESMO, _c2014
300			_a25(1):216–225.
500			_aFormato Vancouver: Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A et al. Spanish Head and Neck Cancer Cooperative Group (TTCC). A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann Oncol. 2014 Jan;25(1):216-25.
501			_aPMID: 24256848
504			_aContiene 15 referencias
520			_aConcurrent chemoradiotherapy (CCRT) is the standard treatment for patients with unresectable, nonmetastatic locoregionally advanced squamous-cell carcinoma of the head and neck (LASCCHN). This randomized, open-label, phase III clinical trial compared the efficacy between standard CCRT and two different induction chemotherapy (ICT) regimens followed by CCRT.
710			_9140 _aServicio de Otorrinolaringología
710			_9303 _aServicio de Oncología Médica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/8/pc895.pdf _ySolicitar documento
942			_n0 _2ddc _cART